Cargando…
Dexmedetomidine and worsening hypoxemia in the setting of COVID-19: A case report
Emergency department management of hypoxemia in the setting of COVID-19 is riddled with uncertainty. The lack of high-quality research has translated to an absence of clarity at the bedside. With disease spread outpacing treatment consensus, provider discretion has taken on a heightened role. Here,...
Autores principales: | Stockton, John, Kyle-Sidell, Cameron |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251409/ https://www.ncbi.nlm.nih.gov/pubmed/32475761 http://dx.doi.org/10.1016/j.ajem.2020.05.066 |
Ejemplares similares
-
Does Hypoxia Itself Beget Worsening Hypoxemia in COVID-19?
por: Chan, Edward D., et al.
Publicado: (2021) -
In Reply — Does Hypoxia Itself Beget Worsening Hypoxemia in COVID-19?
por: Somers, Virend K., et al.
Publicado: (2021) -
Possible silent hypoxemia in a COVID-19 patient: A case report
por: Siswanto, et al.
Publicado: (2020) -
Worsening Hypoxemia in the Face of Increasing PEEP: A Case of Large Pulmonary Embolism in the Setting of Intracardiac Shunt
por: Granati, Glen T., et al.
Publicado: (2016) -
Does Dexmedetomidine Improve or Worsen Restless Leg Syndrome under Sedation: A Case Report and Extensive Review
por: Iskandar, Sandra, et al.
Publicado: (2022)